HEALTH NOTES: Black and Hispanic Cancer Patients Are Underrepresented in Clinical Trials
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.
Yale School of Medicine Joins Health Care Leaders to Advance Equity, Safety
Yale School of Medicine has joined a network of health care leaders organizing across industries to create safe, fair, and dignified workplaces for women. TIME’S UP Healthcare aims to drive new policies and decisions that result in more balanced, diverse, and accountable leadership; address workplace discrimination, harassment and abuse; and create equitable and safe work cultures within all facets of the healthcare industry.
Diversity efforts drive rise in female and minority medical school students
Medical schools in the United States are accepting more women and minority students a decade after diversity standards were introduced by a national accrediting body. According to Yale researchers, the standards are associated with an increase in both the number and proportion of applicants from underrepresented groups, suggesting that the pool of minority talent is sufficient to boost diversity.
Racial Disparities in Genetic Testing of Women With Breast Cancer
MedicalResearch.com Interview with: Cary P. Gross, MD Section of General Internal Medicine Yale University School of Medicine New Haven, CT MedicalResearch.com: What is the background for this study? What are the main findings? Response: Prior work has demonstrated racial and socioeconomic disparities in breast cancer diagnosis, treatment, and outcomes. As the oncology field has progressed over the past decade, the use of genetic testing to guide treatment decisions is one of the most exciting new developments.Source: Medical Research
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
PATHS helps students from underrepresented backgrounds realize med school dreams
Nelson Perez Catalan discovered he was interested in pursuing science while working at a student job at the University of Oregon cleaning glass in the labs. He found himself drawn to research around the brain, and thought about pursuing an MD/PhD, but there was no medical school at his university and as a transplant from Chile, he says much of the U.S. college process was mystifying to him. Then he learned about PATHS, or Program to Advance Training in Health and Sciences at Yale School of Medicine.
Through F-1 Doctors, Yale’s doctors in training make it easier for international students to attend U.S. medical schools
Rachel Jaber Chehayeb wanted to stay in the U.S. to attend medical school after graduating from Yale College, but she knew it would be difficult. As a Lebanese citizen, she would have to navigate visa requirements and loans without nearby family or a ready support network. “I only knew of one person who had done it,” said Chehayeb, a first-year medical student at Yale School of Medicine. “There was not a community of international medical students.”
Support the Diversity You’ve Got: Lessons from the Yale Pediatrics Residency Program
A recent study comparing medical school applicants and enrollees to an age-matched U.S. population from 2002-2017 found that there were no statistically significant trends toward increased representation of minoritized people attending medical school. In fact, the study in JAMA Network Open found that by 2017, Hispanic enrollees were underrepresented by nearly 70%, Black males by nearly 60%, and Black females by nearly 40%.
Crusto Selected for 2021-22 Women's Leadership Fellowship
Cindy Crusto, PhD, Professor of Psychiatry and Deputy Chair for Diversity, Equity and Inclusion in the Department of Psychiatry, has been accepted as a Fellow in the 2021-2022 Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women.
Diversifi: Changing the Face of Healthcare
With their aim of increasing diversity in the medical field, the Diversifi team tackles structural racism in healthcare from multiple angles: the initiative helps make these careers more accessible to underrepresented groups, as well as supports the growth of a workforce that is more capable of providing unbiased healthcare to these populations.
Responding to a Changing World Alumni Spotlight: Dr. Katherine Ciacco Palatianos
During her 27 years of active duty in the U.S. Public Health Service Commissioned Corps, Dr. Katherine Ciacco Palatianos has seen a steady increase in women and people of color working at all levels of public health across the United States.